Vascular Closure Device Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Vascular Closure Device Market will exhibit a 6.3% CAGR from 2024 to 2032, fueled by the increasing number of cardiovascular procedures worldwide. The growing prevalence of cardiovascular diseases, in line with advancements in minimally invasive procedures, is driving the demand for effective and safe vascular closure solutions. The World Health Organization (WHO) reports that cardiovascular diseases are the foremost cause of mortality worldwide, responsible for approximately 17.9 million deaths annually. As the aging population continues to grow, particularly in developed regions, the need for vascular closure devices is expected to rise, supporting market expansion.

The overall Vascular Closure Device Market is segmented based on device type, access, end use, and region.

The passive vascular closure devices will gain substantial traction from 2024 to 2032. Passive vascular closure devices are increasingly preferred due to their simplicity, reliability, and reduced risk of complications. These devices are designed to seal puncture sites after vascular procedures, minimizing bleeding and promoting faster patient recovery. With the rise in cardiovascular interventions such as angioplasty and catheterization, the sales of passive vascular closure devices is expected to surge. Additionally, advancements in device technology, including improved biocompatibility and ease of use, are further driving the adoption of passive vascular closure devices in clinical settings.

The ambulatory surgical centers (ASCs) segment will capture a notable share of the vascular closure device market by 2032. ASCs are becoming increasingly popular due to their cost-effectiveness, convenience, and shorter patient stays compared to traditional hospitals. The rising number of outpatient cardiovascular procedures, driven by the shift towards minimally invasive techniques, is boosting the vascular closure devices demand in ASCs. Furthermore, the growing emphasis on patient safety and the need for efficient postoperative care in ASCs are contributing to the adoption of advanced vascular closure solutions, ensuring quick recovery and reducing the risk of complications.

Europe will drive commendable gains in the vascular closure device market throughout 2024-2032, supported by well-established healthcare infrastructure and significant investments in medical research. The high prevalence of cardiovascular diseases in the region, in line with an aging population, is driving the vascular closure devices sales. Robust regulatory frameworks and government support for healthcare initiatives are fostering innovation and ensuring the quality and safety of medical devices in Europe. The presence of leading medical device manufacturers and ongoing advancements in vascular closure technology are further propelling market growth in the region.

Product Code: 1967

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360°synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing number of patients suffering from cardiovascular diseases
  - 3.2.1.2 Growing geriatric population
  - 3.2.1.3 Technological advancements in vascular closure devices
  - 3.2.1.4 Rising popularity of minimally invasive procedures
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High risk associated with post-procedural complications
  - 3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Vascular closure device market, 2021-2032 (Units)
- 3.6.1 North America
- 3.6.2 Europe
- 3.6.3 Asia Pacific
- 3.6.4 Latin America
- 3.6.5 Middle East and Africa
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Active vascular closure devices
- 5.2.1 Suture-mediated devices
- 5.2.2 Staple clips-mediated vascular closure devices
- 5.2.3 Collagen plug-mediated devices
5.3 Passive vascular closure devices
- 5.3.1 Haemostasis pads/patches
- 5.3.2 Compression devices

Chapter 6 Market Estimates and Forecast, By Access, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Femoral
6.3 Radial

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Poland
- 8.3.7 Sweden
- 8.3.8 Netherlands
- 8.3.9 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Philippines
- 8.4.8 Vietnam
- 8.4.9 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Colombia
- 8.5.5 Chile
- 8.5.6 Peru
- 8.5.7 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Turkey
- 8.6.5 Israel
- 8.6.6 Iran
- 8.6.7 Rest of Middle East and Africa

Chapter 9 Company Profiles

9.1 Abbott Laboratories
9.2 Advanced Vascular Dynamics
9.3 Biotronik SE and Co. KG
9.4 Cardinal Health, Inc.
9.5 Ensite Vascular
9.6 Haemonetics Corporation (cardiva Medical Inc.)
9.7 Marine Polymer Technologies
9.8 Medtronic, Plc
9.9 Merit Medical Systems
9.10 REX MEDICAL
9.11 Teleflex Incorporated
9.12 Terumo Corporation
9.13 Tricol Biomedical
9.14 TZ Medical
9.15 Vasorum Limited